|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300074556 |
|
最近更新日期: Date of Last Refreshed on: |
2023-08-09 15:41:19 |
|
注册时间: Date of Registration: |
2023-08-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
二元应对干预对脊髓损伤患者及其配偶的可行性和初步效果:一项试点随机对照试验 |
|
Public title: |
Feasibility and potential effects of dyadic coping intervention for patients with spinal cord injury and their spouses: a pilot randomised controlled trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
脊髓损伤患者及其配偶二元应对干预方案的构建研究 |
|
Scientific title: |
Construction of dyadic coping intervention program for patients with spinal cord injury and their spouses |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
凤林生 |
研究负责人: |
李伦兰 |
|
Applicant: |
Feng Linsheng |
Study leader: |
Li Lunlan |
|
申请注册联系人电话: Applicant telephone: |
+86 166 0564 3076 |
研究负责人电话:
Study leader's |
+86 138 6613 2269 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1434242948@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
lilunlan@aliyun.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
安徽省合肥市蜀山区梅山路81号 |
研究负责人通讯地址: |
安徽省合肥市蜀山区绩溪路218号 |
|
Applicant address: |
81 Meishan Road, Shushan District, Hefei, Anhui Province, China |
Study leader's address: |
218 Jixi Road, Shushan District, Hefei, Anhui Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
安徽医科大学护理学院 |
||
|
Applicant's institution: |
School of Nursing, Anhui Medical University |
||
|
研究负责人所在单位: |
安徽医科大学第一附属医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Anhui Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
84230026 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
安徽医科大学生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Anhui Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-01-01 00:00:00 | ||
|
伦理委员会联系人: |
程凡 |
||
|
Contact Name of the ethic committee: |
Cheng Fan |
||
|
伦理委员会联系地址: |
安徽省合肥市蜀山区梅山路81号 |
||
|
Contact Address of the ethic committee: |
81 Meishan Road, Shushan District, Hefei, Anhui Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 551 6516 1057 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
安徽医科大学护理学院 |
||||||||||||||||||||||
|
Primary sponsor: |
School of Nursing, Anhui Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
安徽省合肥市蜀山区梅山路81号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
81 Meishan Road, Shushan District, Hefei, Anhui Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
2020年安徽高校自然科学研究项目基金;安徽医科大学护理学院研究生青苗培育项目基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
The fund of Natural Science Research Project of Anhui in2020;The fund of Graduate youth Cultivation Project of School of Nursing, Anhui Medical University |
||||||||||||||||||||||
|
研究疾病: |
脊髓损伤 |
||||||||||||||||||||||
|
Target disease: |
Spinal cord injury |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
构建并应用适用于脊髓损伤患者及配偶的二元应对干预方案,并评价该干预方案的可行性和初步效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
To construct and apply a dyadic coping intervention programme for patients with spinal cord injury and their spouses, and to evaluate the feasibility and preliminary effect of the intervention programme. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)已婚夫妇,年龄≥18岁; (2)根据国际脊髓损伤神经系统分类标准,夫妻一方诊断为SCI,美国脊髓损伤协会(ASIA)分级为B、C、D级; (3)配偶是患者的主要照顾者,并与患者共同生活1年以上; (4)夫妻双方均知情同意参加本研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Married couples, aged ≥18 years old; (2) According to the International Standard for the Neurological Classification of Spinal Cord Injury, one of the spouses was diagnosed with SCI, and the American Spinal Injury Association(ASIA) classification was grade B,C or D; (3) The spouse lived with the patients for more than one year and were the main caregivers of the patient; (4) Both spouses were informed and agreed to participate in this study. |
||||||||||||||||||||||
|
排除标准: |
(1)配偶一方或双方有精神疾病史或严重认知障碍,无法有效沟通; (2)配偶一方或双方合并其他严重躯体疾病,如心力衰竭、呼吸衰竭等。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) One or both spouses had a history of mental illness or severe cognitive impairment, and were unable to communicate effectively; (2)One or both spouses were complicated with other serious physical diseases, such as heart failure, respiratory failure. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-09-01 00:00:00至 To 2024-04-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-09-01 00:00:00 至 To 2024-02-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机序列由一名不参与本研究其他部分的统计学家,在随机化网站上使用区组随机化(区组大小为4或6)生成 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Randomisation lists will stratified by a statistician who will not be involved in any other parts of this study, using block randomisation (block size of four or six) at web-based randomisation tool |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
结局指标测评者不知道分组 |
|
Blinding: |
Outcome assessors will be blinded to group allocation. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究结果将在同行评审的期刊中发表 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The findings will be published in a peer-reviewed journal |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
患者数据将从医院数据库和患者问卷中获取,并将存储在指定计算机上的密码保护文件中 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Patient data will be obtained from the hospital database and patient questionnaire, and will be stored in password-protected files on a designated computer |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |